FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, Jul 14, 2017
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on July 14, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d6581fe3-7cad-41ab-b7b2-1c5a98eebb95
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1024072
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Baxter Healthcare Corporation
19| Date | Classification | Office | Project area |
|---|---|---|---|
| April 2, 2026 | Not classified | Chicago District Office | Drug Quality Assurance |
| November 25, 2025 | Not classified | Chicago District Office | Blood and Blood Products |
| August 1, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 18, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 26, 2018 | Not classified | Chicago District Office |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1311078 - 2026-04-02
- FDA Inspection 1293034 - 2025-11-25
- FDA Inspection 1243362 - 2024-08-01
- FDA Inspection 1215194 - 2023-08-18
- FDA Inspection 1068273 - 2018-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.